230 related articles for article (PubMed ID: 33826785)
21. Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
Botsali A; Esme P; Erbil H; Caliskan E
Lasers Med Sci; 2022 Sep; 37(7):2823-2830. PubMed ID: 35347552
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness and safety of topical methimazole 5% monotherapy versus combination of Q-Switched Nd: YAG Laser and topical methimazole 5% in patients with refractory melasma.
Beyzaee AM; Goldust M; Rokni GR; Patil A; Mostaghiman R; Golpour M
J Cosmet Dermatol; 2023 Jun; 22(6):1774-1779. PubMed ID: 36847668
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
Park SJ; Park JW; Seo SJ; Park KY
Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
[TBL] [Abstract][Full Text] [Related]
24. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
25. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
Kauvar AN
Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
28. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
[TBL] [Abstract][Full Text] [Related]
29. Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial.
Shin JU; Park J; Oh SH; Lee JH
Dermatol Surg; 2013 Mar; 39(3 Pt 1):435-42. PubMed ID: 23278870
[TBL] [Abstract][Full Text] [Related]
30. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma.
Xing X; Chen L; Xu Z; Jin S; Zhang C; Xiang L
J Cosmet Dermatol; 2020 Dec; 19(12):3238-3244. PubMed ID: 33091202
[TBL] [Abstract][Full Text] [Related]
31. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
32. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy.
Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369
[TBL] [Abstract][Full Text] [Related]
33. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
[TBL] [Abstract][Full Text] [Related]
34. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK
J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
[TBL] [Abstract][Full Text] [Related]
35. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
36. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin.
Kim HS; Kim EK; Jung KE; Park YM; Kim HO; Lee JY
J Cosmet Laser Ther; 2013 Jun; 15(3):143-9. PubMed ID: 23607714
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
Lee DB; Suh HS; Choi YS
J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244
[TBL] [Abstract][Full Text] [Related]
38. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.
Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS
Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522
[TBL] [Abstract][Full Text] [Related]
39. The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review.
Lee YS; Lee YJ; Lee JM; Han TY; Lee JH; Choi JE
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888655
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment.
Ertam Sagduyu I; Marakli O; Oraloglu G; Bulut Okut E; Unal I
Dermatol Ther; 2022 Dec; 35(12):e15970. PubMed ID: 36346028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
